Log In
Print this Print this

TRIA-662 (formerly 1-MNA)

  Manage Alerts
Collapse Summary General Information
Company Pharmena S.A.
DescriptionMetabolite of niacin
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDyslipidemia
Indication DetailsTreat Dyslipidemia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today